[Federal Register Volume 80, Number 141 (Thursday, July 23, 2015)]
[Notices]
[Page 43779]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-18065]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee: Notice of 
Charter Amendment

    This gives notice under the Federal Advisory Committee Act (Pub. L. 
92-463) of October 6, 1972, that the Clinical Laboratory Improvement 
Advisory Committee, Centers for Disease Control and Prevention (CDC), 
Department of Health and Human Services (HHS), has amended their 
charter to reduce the number of annual meetings and to change the 
designation of CDC, FDA and CMS from voting to non-voting ex officio 
members. The amended filing date is July 9, 2015.
    For information, contact Nancy Anderson, Chief, Laboratory Practice 
Standards Branch, Division of Laboratory Programs, Standards, and 
Services, Center for Surveillance, Epidemiology and Laboratory 
Services, Office of Public Health Scientific Services, CDC, 1600 
Clifton Road, NE., Mailstop F-11, Atlanta, Georgia 30329-4018; 
telephone (404) 498-2741.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-18065 Filed 7-22-15; 8:45 am]
BILLING CODE 4163-18-P